Insider plans sale of 16,823 company shares

A holder of common stock has filed a Form 144 notice to potentially sell 16,823 shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an indicated aggregate market value of $29,051.64.

Rhea-AI Filing Summary

A holder of common stock has filed a Form 144 notice to potentially sell 16,823 shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an indicated aggregate market value of $29,051.64. The issuer reports 224,730,144 shares of common stock outstanding.

The shares to be sold were acquired as restricted stock vesting under a registered plan on January 31, 2026, treated as compensation from the issuer. The same individual previously sold 786 common shares on November 17, 2025, generating gross proceeds of $958.92.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ALLO Form 144 filing disclose about upcoming share sales?

The Form 144 filing discloses a planned sale of 16,823 common shares with an indicated market value of $29,051.64. These shares may be sold on the NASDAQ through Morgan Stanley Smith Barney LLC, subject to Rule 144 conditions.

How many ALLO shares is the insider planning to sell under this Form 144?

The filer indicates an intent to sell 16,823 common shares. The filing also notes that the issuer has 224,730,144 common shares outstanding, providing context for the size of the potential transaction relative to total equity.

How and when were the ALLO shares in this Form 144 acquired?

The 16,823 shares were acquired as restricted stock vesting under a registered plan on January 31, 2026. The filing describes the nature of payment as compensation from the issuer rather than a cash purchase.

Has the ALLO insider sold any shares in the past three months?

Yes. The filing reports a prior sale of 786 common shares on November 17, 2025, generating $958.92 in gross proceeds. This historical activity is disclosed as required for sales during the preceding three months.

Which broker is handling the potential ALLO share sale in this Form 144?

The potential sale is designated to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The shares are expected to be sold on the NASDAQ market.

What is the approximate timing for the proposed ALLO share sale?

The filing lists an approximate date of sale of February 2, 2026 for the 16,823 common shares. This date reflects when the filer expects to begin selling the securities under Rule 144, subject to market conditions and applicable rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:49 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002057918
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALLOGENE THERAPEUTICS, INC.
SEC File Number	001-38693
Address of Issuer	210 East Grand Avenue South San Francisco CALIFORNIA 94080
Phone	(650) 457-2700
Name of Person for Whose Account the Securities are To Be Sold	BENJAMIN M BENESKI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	16823	29051.64	224730144	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted stock vesting under a registered plan	Issuer			16823	01/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Beneski 210 East Grand Avenue South San Francisco CA 94080	Common	11/17/2025	786	958.92

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Benjamin Beneski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)